| scholarly article | Q13442814 |
| P2093 | author name string | Christina Chan | |
| Hirosha Geekiyanage | |||
| P2860 | cites work | Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation | Q21194851 |
| Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I | Q24301846 | ||
| Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels | Q24314953 | ||
| A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation | Q24608565 | ||
| The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs | Q24627506 | ||
| MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index | Q24628888 | ||
| miRBase: tools for microRNA genomics | Q24649872 | ||
| The microRNA.org resource: targets and expression | Q24650094 | ||
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis | Q28139061 | ||
| A detergent-insoluble membrane compartment contains A beta in vivo | Q47982783 | ||
| Sex-specific radiation-induced microRNAome responses in the hippocampus, cerebellum and frontal cortex in a mouse model | Q48194870 | ||
| Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus | Q48266570 | ||
| High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model | Q48877805 | ||
| Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. | Q48933018 | ||
| Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study | Q53295392 | ||
| Ceramide and sphingomyelin species of fibroblasts and neurons in culture | Q57375110 | ||
| Ketogenic diet in Rett syndrome | Q73184781 | ||
| Molecular genetics of Alzheimer's disease | Q77910325 | ||
| Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 | ||
| Spatial segregation of gamma-secretase and substrates in distinct membrane domains | Q28591973 | ||
| A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
| Meta-analysis of linkage studies for Alzheimer's disease--a web resource | Q30484112 | ||
| Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring | Q33511008 | ||
| Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta | Q33605734 | ||
| Deregulation of sphingolipid metabolism in Alzheimer's disease | Q33693061 | ||
| The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. | Q33722837 | ||
| Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons | Q33762153 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| Context-dependent functions of specific microRNAs in neuronal development | Q34220566 | ||
| Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease | Q34489852 | ||
| Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase | Q34571804 | ||
| Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein | Q34649008 | ||
| Ceramide structure predicts tumor ganglioside immunosuppressive activity | Q35084457 | ||
| Non-coding RNAs in the nervous system | Q36523588 | ||
| Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
| Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression | Q36609033 | ||
| ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain | Q37379675 | ||
| MicroRNAs in brain development and physiology | Q37619095 | ||
| Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. | Q38291637 | ||
| Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. | Q38321708 | ||
| miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. | Q39674586 | ||
| Identification of gliotropic factors that induce human stem cell migration to malignant tumor | Q39863377 | ||
| Inhibition by KMI-574 leads to dislocalization of BACE1 from lipid rafts | Q39938837 | ||
| Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways | Q39975165 | ||
| Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling | Q40625434 | ||
| The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans | Q41914523 | ||
| A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1. | Q42177453 | ||
| Endotoxin activates de novo sphingolipid biosynthesis via nuclear factor kappa B-mediated upregulation of Sptlc2. | Q42183157 | ||
| Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities | Q42507824 | ||
| Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. | Q43143033 | ||
| Brain membrane phospholipid alterations in Alzheimer's disease | Q43743686 | ||
| Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis | Q44163309 | ||
| Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis | Q44370232 | ||
| Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice | Q45182276 | ||
| Therapeutic effects of a ketogenic diet in Rett syndrome | Q46156332 | ||
| Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin. | Q46335285 | ||
| Alzheimer peptides perturb lipid-regulating enzymes | Q46873173 | ||
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| microRNA | Q310899 | ||
| P304 | page(s) | 14820-14830 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease | |
| P478 | volume | 31 |
| Q27499741 | A blood based 12-miRNA signature of Alzheimer disease patients |
| Q48348498 | A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity |
| Q37122270 | A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. |
| Q92861486 | Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice |
| Q41994998 | Activation of the NLRP3 inflammasome in microglia: The role of ceramide |
| Q38681920 | Alzheimer's Disease and ncRNAs. |
| Q26996487 | Alzheimer's disease and insulin resistance: translating basic science into clinical applications |
| Q64068117 | Amyloid Beta and MicroRNAs in Alzheimer’s Disease |
| Q34788620 | Analysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosis |
| Q59247478 | Application of An Improved HPLC-FL Method to Screen Serine Palmitoyl Transferase Inhibitors |
| Q38481462 | Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease? |
| Q34177537 | Association of a miRNA-137 polymorphism with schizophrenia in a Southern Chinese Han population. |
| Q55378706 | Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese. |
| Q37342459 | Biomarkers of chemotherapy-induced testicular damage |
| Q35991723 | Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease |
| Q38189850 | Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. |
| Q35875886 | Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration |
| Q38224066 | Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases |
| Q90720272 | Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis |
| Q37158033 | Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies |
| Q38214427 | Circulating miRNAs as biomarkers for neurodegenerative disorders. |
| Q35162753 | Circulating miRNAs in ageing and ageing-related diseases |
| Q27021084 | Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers |
| Q48713195 | Circulating microRNAs in Neurodegenerative Diseases. |
| Q38103194 | Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases |
| Q38041425 | Decoding the non-coding RNAs in Alzheimer's disease |
| Q48916102 | Design and Fabrication a Gold Nanoparticle-DNA Based Nanobiosensor for Detection of microRNA Involved in Alzheimer's Disease. |
| Q50535417 | Downregulated serum miR-223 servers as biomarker in Alzheimer's disease. |
| Q38612032 | Dysregulation and diagnostic potential of microRNA in Alzheimer's disease |
| Q47426247 | Effects of XIST/miR-137 axis on neuropathic pain by targeting TNFAIP1 in a rat model. |
| Q38225708 | Epigenetic drug discovery for Alzheimer's disease |
| Q33858861 | Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. |
| Q97570185 | Epigenetic mechanisms in Alzheimer's disease |
| Q33841944 | Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease |
| Q26772028 | Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response |
| Q34518584 | Epigenomics of Alzheimer's disease |
| Q99417473 | Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides |
| Q47224473 | GIMDA: Graphlet interaction-based MiRNA-disease association prediction. |
| Q40689258 | Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease |
| Q35771016 | High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model |
| Q37320087 | IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease |
| Q43154122 | Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease. |
| Q36323567 | Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder |
| Q92994454 | Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence |
| Q36836935 | Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease |
| Q36355055 | Lack of miRNA Misregulation at Early Pathological Stages in Drosophila Neurodegenerative Disease Models. |
| Q38989183 | MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets |
| Q38952716 | MiR-137: an important player in neural development and neoplastic transformation. |
| Q40581942 | MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors |
| Q21129476 | Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders |
| Q58785403 | Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells |
| Q33675828 | MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX |
| Q39185826 | MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia |
| Q38202497 | MicroRNAs and Molecular Mechanisms of Neurodegeneration. |
| Q38132116 | MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled |
| Q39215093 | MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease. |
| Q46822603 | MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease |
| Q35802248 | MicroRNAs: New Players in Anesthetic-Induced Developmental Neurotoxicity |
| Q36881831 | Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions |
| Q38051910 | Neurodegeneration as an RNA disorder |
| Q90399950 | Neuroinflammation as a Common Feature of Neurodegenerative Disorders |
| Q30363059 | Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse |
| Q45069913 | Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase |
| Q38051212 | Non-coding RNAs in Alzheimer's disease |
| Q50072580 | Noncoding RNAs in Alzheimer's disease |
| Q34227170 | Ontogeny of small RNA in the regulation of mammalian brain development |
| Q42589440 | Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases |
| Q92668853 | Possible epigenetic regulatory effect of dysregulated circular RNAs in Alzheimer's disease model |
| Q30454963 | Potential Impact of miR-137 and Its Targets in Schizophrenia |
| Q57157878 | Quantitative Systems Pharmacology Model for Alzheimer's Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option |
| Q38746607 | Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells |
| Q91771264 | RNA Granules and Their Role in Neurodegenerative Diseases |
| Q55004951 | Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases. |
| Q58730164 | Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis |
| Q38017136 | Regulation of iron homeostasis by microRNAs |
| Q97530319 | Robust light-dark patterns and reduced amyloid load in an Alzheimer's disease transgenic mouse model |
| Q92824866 | Role of miRNAs in Alzheimer's Disease and Possible Fields of Application |
| Q90417635 | Role of viruses, prions and miRNA in neurodegenerative disorders and dementia |
| Q37380788 | SOT Symposium Highlight: Translatable Indicators of Testicular Toxicity: Inhibin B, MicroRNAs, and Sperm Signatures |
| Q37615645 | Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease |
| Q33753317 | Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis? |
| Q36121819 | The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden |
| Q35966911 | The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders |
| Q90523100 | The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer |
| Q41037858 | The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer's Disease |
| Q51760979 | The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials. |
| Q37080125 | The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. |
| Q34426210 | The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q48140110 | The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia |
| Q37360734 | The human transcriptome is enriched for miRNA-binding sites located in cooperativity-permitting distance |
| Q26858788 | The involvement of microRNAs in neurodegenerative diseases |
| Q38539519 | The pathogenic role of the inflammasome in neurodegenerative diseases |
| Q26996822 | The role of inflammasome in Alzheimer's disease |
| Q38699120 | Tibolone Preserves Mitochondrial Functionality and Cell Morphology in Astrocytic Cells Treated with Palmitic Acid. |
| Q38979078 | Transcriptional targets of the schizophrenia risk gene MIR137. |
| Q42272607 | Upregulation of miR-137 protects anesthesia-induced hippocampal neurodegeneration. |
| Q38975341 | Upregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice |
| Q33738316 | Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. |
| Q89761067 | miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer's Disease |
| Q92187683 | miRNA-Dependent Control of Homeostatic Plasticity in Neurons |
| Q38623016 | miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease. |
| Q37535111 | miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy |
| Q38648154 | microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases |
Search more.